Cathie Wood's Ark Innovation ETF invested in biotech stocks Intellia Therapeutics and Recursion Pharmaceuticals, focusing on disruptive innovation and AI technology. While these stocks offer potential, they come with high risk due to unproven therapies and regulatory hurdles. Consider these investments cautiously.